The Structural Genomics Consortium

a public-private partnership that supports the discovery of new medicines through open access research.

The Structural Genomics Consortium (SGC) catalyses research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. It accelerates research in these new areas by making all its research output fully available to the scientific community, and by creating an open collaborative network of scientists in hundreds of universities around the world and in nine global pharmaceutical companies.

Together, this network of academic and industry scientists is driving a new scientific and drug discovery ecosystem whose primary aim is to advance science, without the influence of personal, institutional, or commercial gain.


Featured

License Type: Other
Media Types: Articles
Subject Area: Maths & Science